Once-Weekly Oral Combo for HIV Maintains High Rates of Virologic Suppression
08/05/2026
Estudio de combinación semanal A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of
Pennsylvania officials have reported a fourth measles-associated death. Detalles del caso El último fallecimiento involucra a un residente de 18…
Read more →
Estudio de combinación semanal A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of
Suppressing a sneeze may have led to a spontaneous leak of cerebrospinal fluid (CSF) and air entering the skull of
NfL and Cognition Neurofilament light chain (NfL), a measure of neuronal injury, emerged as a key blood-based biomarker associated with
Introducción The interleukin-6 (IL-6) inhibitor satralizumab (Enspryng) met its primary endpoint in the phase III METEOROID trial of myelin oligodendrocyte